# SHOX2

## Overview
The SHOX2 gene encodes the SHOX homeobox 2 protein, a transcription factor that plays a pivotal role in the regulation of developmental processes, particularly in skeletal and cardiac development. As a member of the paired homeobox gene family, SHOX2 is characterized by its homeobox domain, which facilitates its function as a DNA-binding protein, allowing it to regulate the expression of target genes. This transcription factor is involved in the development of the early embryonic body structure and the cardiac autonomic rhythm system, influencing cellular differentiation and skeletal formation. SHOX2 interacts with other transcription factors, such as SOX5, SOX6, and SOX9, to modulate chondrogenesis and skeletal development. It is also crucial for the proper functioning of the sinoatrial node, which is essential for cardiac pacemaker activity. Mutations in the SHOX2 gene have been linked to various cardiac and skeletal disorders, underscoring its clinical significance (AbassahOppong2020A; Hoffmann2016Coding; Li2020Signaling).

## Structure
The SHOX2 gene encodes a transcription factor that plays a critical role in skeletal development. The protein product of SHOX2 contains a homeobox domain, which is a DNA-binding motif essential for its function. This domain is a key feature of the protein's molecular structure, allowing it to bind to specific DNA sequences and regulate gene expression. The presence of the homeobox domain suggests a highly conserved structure that is crucial for its role in transcriptional regulation.

Post-translational modifications, such as phosphorylation, may regulate the activity of the SHOX2 protein, potentially influencing its interaction with other molecules and its stability. These modifications can alter the protein's function and are important for its regulatory roles in the cell.

Alternative splicing of the SHOX2 gene can result in different isoforms of the protein. These isoforms may have variations in their structural and functional properties, which could impact their role in skeletal development. The existence of multiple isoforms indicates a level of complexity in the regulation and function of the SHOX2 protein, allowing it to participate in diverse biological processes.

## Function
The SHOX2 gene encodes a transcription factor that plays a critical role in the regulation of developmental processes in humans. It is part of the paired homeobox gene family and is highly homologous to the SHOX gene, sharing significant functional overlap (Li2020Signaling). SHOX2 is involved in the development of the early embryonic body structure and the cardiac autonomic rhythm system by regulating cellular differentiation. It interacts with chondrogenic transcription factors such as SOX5, SOX6, and SOX9, and activates the Agc1 enhancer, which is essential for chondrogenesis and skeletal development (Li2020Signaling).

In the context of cardiac development, SHOX2 is expressed in the heart and is crucial for the proper functioning of the sinoatrial node (SAN), which is essential for cardiac pacemaker activity (AbassahOppong2020A). The gene is also expressed in various tissues, including the limb skeleton, nose, gill arches, nervous system, and human embryonic reproductive nodules, indicating its broad role in embryonic development (Li2020Signaling). SHOX2 functions as a bidirectional transcription regulator, capable of acting as both an activator and repressor, depending on the cell type-specific cofactors present (Li2020Signaling).

## Clinical Significance
Mutations and alterations in the SHOX2 gene are associated with several cardiac and skeletal conditions. In the context of cardiac health, SHOX2 mutations have been linked to early-onset atrial fibrillation (AF) and sinus node dysfunction (SND). Specific mutations, such as p.G81E, p.H283Q, and p.R194X, have been identified in patients with AF, with some variants affecting the gene's ability to activate target genes like BMP4 and ISL1, leading to impaired cardiac conduction (Li2018A; Hoffmann2016Coding). The p.R194X mutation, in particular, results in a truncated protein and is associated with familial AF, exhibiting an autosomal dominant inheritance pattern (Li2018A). 

Alterations in SHOX2 expression levels, such as those caused by a 3' UTR variant creating a binding site for miR-92b-5p, have been linked to AF by affecting the heart's electrical properties, including prolonged PR intervals (Hoffmann2016Coding). In zebrafish models, certain SHOX2 mutations have shown dominant-negative effects, leading to reduced heart rates and pericardial edema, further implicating SHOX2 in cardiac arrhythmias (Hoffmann2019Functional).

In skeletal development, overexpression of SHOX2 in mice has been associated with congenital dysplasia of the temporomandibular joint (TMJ), characterized by alterations in extracellular matrix components and increased apoptosis, potentially leading to TMJ disorders (Li2014Overexpression).

## Interactions
SHOX2 is a transcription factor that plays a significant role in skeletal development through its interactions with various proteins. It interacts with SOX5 and SOX6, with a stronger interaction observed with SOX6. This interaction is mediated by the homeodomain of SHOX2 and the HMG domain of SOX6, with the coiled-coil domain of SOX6 providing additional stability (AzaCarmona2014NPPB). SHOX2 also interacts with SHOX, another protein involved in limb development. The interaction between SHOX2 and SHOX involves the homeodomain and the C-terminal region of SHOX2, including the OAR domain, which are necessary for the interaction (AzaCarmona2014NPPB).

SHOX2 is coexpressed with SHOX, SOX5, SOX6, and SOX9 in human fetal tibia growth plates, suggesting a coordinated role in skeletal development (AzaCarmona2014NPPB). It regulates the expression of the natriuretic peptide precursor B gene (NPPB) and Aggrecan (ACAN) by directly activating NPPB and cooperating with the SOX trio to activate ACAN (AzaCarmona2014NPPB). The interactions of SHOX2 with these transcription factors are crucial for the proper development of skeletal structures, highlighting the importance of specific domains in these protein interactions (AzaCarmona2014NPPB).


## References


[1. (Li2014Overexpression) Xihai Li, Wenna Liang, Hongzhi Ye, Xiaping Weng, Fayuan Liu, and Xianxiang Liu. Overexpression of shox2 leads to congenital dysplasia of the temporomandibular joint in mice. International Journal of Molecular Sciences, 15(8):13135–13150, July 2014. URL: http://dx.doi.org/10.3390/ijms150813135, doi:10.3390/ijms150813135. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms150813135)

[2. (Hoffmann2016Coding) Sandra Hoffmann, Sebastian Clauss, Ina M. Berger, Birgit Weiß, Antonino Montalbano, Ralph Röth, Madeline Bucher, Ina Klier, Reza Wakili, Hervé Seitz, Eric Schulze-Bahr, Hugo A. Katus, Friederike Flachsbart, Almut Nebel, Sabina PW. Guenther, Erik Bagaev, Wolfgang Rottbauer, Stefan Kääb, Steffen Just, and Gudrun A. Rappold. Coding and non-coding variants in the shox2 gene in patients with early-onset atrial fibrillation. Basic Research in Cardiology, April 2016. URL: http://dx.doi.org/10.1007/s00395-016-0557-2, doi:10.1007/s00395-016-0557-2. This article has 37 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s00395-016-0557-2)

[3. (Li2020Signaling) Nanhong Li, Yu Zeng, and Jian Huang. Signaling pathways and clinical application of rassf1a and shox2 in lung cancer. Journal of Cancer Research and Clinical Oncology, 146(6):1379–1393, April 2020. URL: http://dx.doi.org/10.1007/s00432-020-03188-9, doi:10.1007/s00432-020-03188-9. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00432-020-03188-9)

4. (AbassahOppong2020A) A gene desert required for regulatory control of pleiotropicShox2expression and embryonic survival. This article has 3 citations.

[5. (AzaCarmona2014NPPB) Miriam Aza-Carmona, Veronica Barca-Tierno, Alfonso Hisado-Oliva, Alberta Belinchón, Darya Gorbenko-del Blanco, Jose Ignacio Rodriguez, Sara Benito-Sanz, Angel Campos-Barros, and Karen E. Heath. Nppb and acan, two novel shox2 transcription targets implicated in skeletal development. PLoS ONE, 9(1):e83104, January 2014. URL: http://dx.doi.org/10.1371/journal.pone.0083104, doi:10.1371/journal.pone.0083104. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0083104)

[6. (Li2018A) Ning Li, Zhang-Sheng Wang, Xin-Hua Wang, Ying-Jia Xu, Qi Qiao, Xiu-Mei Li, Ruo-Min Di, Xiao-Juan Guo, Ruo-Gu Li, Min Zhang, Xing-Biao Qiu, and Yi-Qing Yang. A shox2 loss-of-function mutation underlying familial atrial fibrillation. International Journal of Medical Sciences, 15(13):1564–1572, 2018. URL: http://dx.doi.org/10.7150/ijms.27424, doi:10.7150/ijms.27424. This article has 28 citations and is from a peer-reviewed journal.](https://doi.org/10.7150/ijms.27424)

[7. (Hoffmann2019Functional) Sandra Hoffmann, Christoph Paone, Simon A. Sumer, Sabrina Diebold, Birgit Weiss, Ralph Roeth, Sebastian Clauss, Ina Klier, Stefan Kääb, Andreas Schulz, Philipp S. Wild, Adil Ghrib, Tanja Zeller, Renate B. Schnabel, Steffen Just, and Gudrun A. Rappold. Functional characterization of rare variants in the shox2 gene identified in sinus node dysfunction and atrial fibrillation. Frontiers in Genetics, July 2019. URL: http://dx.doi.org/10.3389/fgene.2019.00648, doi:10.3389/fgene.2019.00648. This article has 21 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2019.00648)